Home532296 • BOM
add
Glenmark Pharmaceuticals Ltd
Nakaraang pagsara
₹1,523.35
Sakop ng araw
₹1,493.05 - ₹1,533.00
Sakop ng taon
₹764.25 - ₹1,830.05
Market cap
416.00B INR
Average na Volume
12.65K
P/E ratio
-
Dividend yield
0.17%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 34.34B | 7.06% |
Gastos sa pagpapatakbo | 18.82B | 11.45% |
Net na kita | 3.54B | 532.26% |
Net profit margin | 10.32 | 504.71% |
Kita sa bawat share | 12.55 | — |
EBITDA | 6.01B | 26.34% |
Aktuwal na % ng binabayarang buwis | 24.99% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 18.20B | 61.94% |
Kabuuang asset | 152.35B | -23.85% |
Kabuuang sagutin | 67.90B | -33.89% |
Kabuuang equity | 84.45B | — |
Natitirang share | 282.24M | — |
Presyo para makapag-book | 5.09 | — |
Return on assets | — | — |
Return on capital | 12.47% | — |
Cash Flow
Net change in cash
(INR) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 3.54B | 532.26% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, India. Wikipedia
Itinatag
1977
Website
Mga Empleyado
14,989